You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 3, March 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Papillomavirus, Human
 •Psoriasis
 •Phototherapy
 •Alert me on articles by topic

Increased Prevalence of Human Papillomavirus in Hairs Plucked From Patients With Psoriasis Treated With Psoralen–UV-A

Peter Wolf, MD; Hannes Seidl, PhD; Barbara Bäck; Barbara Binder, MD; Gerald Höfler, MD; Franz Quehenberger, PhD; Christine Hoffmann, MD; Helmut Kerl, MD; Sabine Stark, PhD; Herbert J. Pfister, PhD; Pawel G. Fuchs, PhD

Arch Dermatol. 2004;140:317-324.

Background  Patients with psoriasis treated with psoralen–UV-A (PUVA) are at increased risk of skin cancer; however, the exact causes of this increased incidence are not well understood. It has been suggested that PUVA may increase expression of the tumorigenic agent human papillomavirus (HPV) in skin by directly stimulating virus replication, immune suppression, or both, thereby leading to skin cancer formation.

Objective  To determine whether HPV DNA prevalence in the skin is increased after long-term PUVA treatment.

Design  Screening for the presence of HPV sequences in DNA isolated from plucked body hairs of patients with psoriasis with a history of PUVA exposure and a history of skin cancer (group A), PUVA exposure and no history of skin cancer (group B), and no PUVA exposure and no history of skin cancer (group C).

Setting  University hospital.

Patients and Methods  Hair samples were obtained from 81 patients with psoriasis (56 men and 25 women; mean age, 52 years), including 16 in group A (mean number of PUVA exposures, 702), 35 in group B (mean number of PUVA exposures, 282), and 30 in group C. DNA was isolated from the hair samples and analyzed by polymerase chain reaction with the use of 2 nested primer systems specific for epidermodysplasia verruciformis–associated or related and genital or mucosal virus types, respectively.

Results  The rate of HPV DNA positivity was significantly higher in groups A (73% [11/15]) and B (69% [24/35]) than in group C (36% [10/28]) (A + B vs C, P = .009; {chi}2 test; age adjusted).

Conclusion  The prevalence of HPV in the skin (hair follicles) is increased in patients with psoriasis who have a history of PUVA exposure.


From the Department of Photodermatology (Dr Wolf), Department of Dermatology (Drs Wolf, Seidl, Binder, Hoffmann, and Kerl and Ms Bäck), Institute of Pathology (Dr Höfler), and Institute of Medical Informatics, Statistics, and Documentation (Dr Quehenberger), Karl-Franzens-University, Graz, Austria; and Institute of Virology, Cologne Center for Molecular Medicine, University of Cologne, Cologne, Germany (Drs Stark, Pfister, and Fuchs). The authors have no relevant financial interest in this article.
Dr Fuchs is deceased.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.